• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy House Republicans accuse NIH of ‘stonewalling’ on ‘supercharged monkeypox experiment’
Economy

House Republicans accuse NIH of ‘stonewalling’ on ‘supercharged monkeypox experiment’

by April 2, 2023
by April 2, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

House Republicans are pressing the National Institutes of Health (NIH) for answers after the agency funded research experiments they say could result in a ‘supercharged’ monkeypox virus. 

In a letter to acting NIH Director Lawrence Tabak, House Energy and Commerce Committee Chair Cathy McMorris Rodgers, R-Wash., and two subcommittee chairmen are demanding that the agency turn over documents and information regarding a government-funded experiment that reportedly involves swapping monkepox genes with a deadlier version of the virus. The lawmakers want to know whether this project was approved by the Department of Health and Human Services (HHS) review board tasked with oversight of research involving enhanced pathogens that could potentially cause a pandemic. 

This letter is a follow-up to an October 31, 2022, letter to which Republicans say the NIH never responded. GOP lawmakers accused NIH of ‘stonewalling’ in a press release. 

‘Based on the available information, it appears the project is reasonably anticipated to yield a lab-generated monkeypox virus that is 1,000 times more lethal in mice than the monkeypox virus currently circulating in humans and that transmits as efficiently as the monkeypox virus currently circulating in humans. The risk-benefit ratio indicates potentially serious risks without clear civilian practical applications,’ the Republicans wrote. 

‘Accordingly, this experiment would seem to involve risks reasonably anticipated to create, transfer, or use [potential pandemic pathogens] resulting from the enhancement of a pathogen’s transmissibility or virulence in humans. Thus, under the circumstances, we are interested in learning whether this experiment was reviewed under the HHS P3CO framework used to review research proposals posing significant biosafety or biosecurity risks.’ 

The project leader is Dr. Bernard Moss, a veteran poxvirus researcher at the U.S. National Institute of Allergy and Infectious Diseases. An article in Science magazine described his efforts to learn the differences between two variants of monkeypox virus: clade 2, the West African variant that caused a global outbreak last year, and clade 1, which is believed to be deadlier and has caused outbreaks in the Democratic Republic of Congo for decades. 

Moss’ research involves swapping the genes of the two variants, one at a time, to discover whether a specific gene in the clade 1 virus makes it deadlier. The Republicans want to know whether these lab experiments could artificially enhance the clade 2 variant. 

Such research, known as ‘gain-of-function,’ is highly controversial, because it involves extracting viruses from animals to artificially engineer in a laboratory to make them more transmissible and deadly to humans. Proponents say these experiments can help scientists understand the nature of viruses and develop new treatments and vaccines. Skeptics warn that gain-of-function experiments are one lab accident away from causing another global pandemic. 

Moss did not immediately respond to a request for comment. 

‘Human disease associated with clade 2 or West African monkeypox virus infection is less severe and is associated with less than one percent mortality, whereas clade 1 or Congo Basin monkeypox infection has a 10 percent case fatality rate in unvaccinated persons,’ the Republicans wrote. ‘Because of its significantly greater lethality, clade 1 or Congo Basin clade monkeypox viruses are regulated as select agents by the Federal Select Agents Program. Entities that possess, use, or transfer this agent must comply with the HHS Select Agent and Toxin Regulations unless there is an applicable exemption or exclusion. 

‘Thus,’ the letter continues, ‘under these regulations, it would appear the clade 1 monkeypox virus experiment is a restricted experiment that must be reviewed by the Federal Select Agent Program, and may be further reviewed by the Centers for Disease Control and Prevention‘s (CDC’s) Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC).’ 

The Republicans want NIH officials and employees to testify about Moss’ project and other related matters. They gave NIH an April 13, 2023, deadline to respond to their inquiry. 

Chris Pandolfo is a writer for Fox News Digital. Send tips to chris.pandolfo@fox.com and follow him on Twitter @ChrisCPandolfo.

This post appeared first on FOX NEWS
You Might Also Like
  • George Santos delivers speech on Holocaust remembrance after lying about Jewish heritage
  • Biden joins AOC in linking Canadian wildfires to ‘climate crisis’
  • Six House Dems vote with GOP to condemn Kamala Harris for ‘border czar’ role
  • White House ignores Republicans demanding answers on Biden’s knowledge of Hunter Biden’s business dealings
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Week Ahead: NIFTY Defends Key Supports; Upside May Stay Capped Here In This Short 3-Day Week
next post
DeSantis targets Biden in swing state Pennsylvania, says Democratic Party ‘dead’ in Florida

You may also like

Biden’s Pentagon nominee grilled on selling of border wall parts,...

January 25, 2024

Chinese hackers preparing to ‘wreak havoc’ on American citizens, communities,...

January 31, 2024

Rep. Stefanik reportedly plans $100M ‘guerilla warfare’ campaign push to...

August 28, 2023

Ex-Israeli defense minister says Iran planning nuclear Holocaust as regime...

June 8, 2024

DeSantis’ governorship timeline coincides with a presidential campaign return: expert

January 25, 2024

Trump will not visit Capitol Hill ahead of House speaker...

October 10, 2023

Secret meeting between US, Israel, UAE held to discuss postwar...

July 23, 2024

Trump recommends North Carolina GOP Chair Whatley to replace McDaniel...

February 8, 2024

Former Trump officials skeptical of Biden admin’s reported plan to...

March 12, 2023

SafeMoon and Litecoin: Support Levels and Targets

October 24, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Oil prices rise more than 1% as Israel vows to intensify attacks on Iran

      June 20, 2025
    • RRG Alert Tech Vaults to ‘Leading’—Is XLK Signaling a New Rally?

      June 20, 2025
    • Apple looking to make ‘premium’-priced folding iPhones starting next year, analyst says

      June 20, 2025
    • Nike pushes back Skims launch with Kim Kardashian due to production delays

      June 19, 2025
    • The Fed Is Getting It Wrong AGAIN As They Hold Rates Steady

      June 19, 2025

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 3,599 views
    • 2

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,874 views
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,578 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,541 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,417 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,142)
    • Investing (538)
    • Stock (2,621)

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Oil prices rise more than 1% as Israel vows to...

      June 20, 2025
    • RRG Alert Tech Vaults to ‘Leading’—Is XLK Signaling a New...

      June 20, 2025
    • Apple looking to make ‘premium’-priced folding iPhones starting next year,...

      June 20, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,142)
    • Investing (538)
    • Stock (2,621)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Mace calls Texas mifepristone ruling ‘unconstitutional,’...

    April 11, 2023

    Republicans warn of mass exodus from...

    October 6, 2023

    Experts weigh in on liberal ‘freak...

    April 9, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here